GXO Reports First Quarter 2025 Results
1. GXO's Q1 revenue increased 21% to $3 billion year-over-year. 2. Sales pipeline reached a three-year high of $2.5 billion. 3. Company repurchased 2.8 million shares, signaling confidence. 4. Reaffirmed full-year guidance for organic growth and adjusted EBITDA. 5. Notable new contract with NHS valued at $2.5 billion.